Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Telmediq Recognized in the Gartner Market Guide for Clinical Communication and Collaboration


SEATTLE, July 23, 2018 /PRNewswire/ -- Telmediq announced today that it has been listed as a Representative Vendor in Gartner's 2018 Market Guide for Clinical Communication and Collaboration. Telmediq unifies texting, voice communications, alerting, pagers, on-call schedules and the call center to improve clinical communication and workflows.

Telmediq Secure Messaging Logo (PRNewsfoto/Telmediq)

"CC&C is critical to becoming a next-generation healthcare provider," notes Gartner Analyst Barry Runyon, "Moving off the status quo requires implementing new programs surrounding IT consolidation, standardization, automation, instrumentation, integration, performance monitoring, and system decommissioning, as well as extending the reach of IT into new venues of care."1

According to the report, "Healthcare provider CIOs and clinical leadership should use this guide to see where this market is heading and identify notable vendors."

Telmediq is the first company to forward patient alarms and nurse calls through a central, cloud-based solution and the only company that can integrate with a hospital's non-session initiation protocol (non-SIP)/VoIP hospital switch via the public switched telephone network (PSTN). Telmediq was also the first company to include call center capability with a unified communication platform in healthcare using a cloud delivery model.

"Point solutions create additional technology and user silos that aren't providing clinicians what they need," notes Ben Moore, Telmediq CEO, "Clinical communication and collaboration platforms such as Telmediq are helping remove these silos and create an environment of rich patient data to improve critical workflows, care coordination and the patient experience."

Gartner Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Telmediq
Telmediq is the #1 KLAS rated vendor for secure communication platforms for large hospital systems, acute-care and ambulatory facilities. Telmediq unifies communication by integrating 20+ clinical systems (EHR, schedules, call center, alarms, nurse call) to improve workflow and connect care team members. www.telmediq.com

1 Gartner "Market Guide for Clinical Communication and Collaboration" by Barry Runyon, 12 July 2018.

SOURCE Telmediq


These press releases may also interest you

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...



News published on and distributed by: